SIGNATURE BIOSCIENCE
Signature BioScience Inc. was the first biotechnology company based in San Francisco. It was formed in 1998 but closed in 2003 due to lack of funding. Before Signature was dissolved, it had just completed Phase II trials on Digitoxin, which the company was pursuing as an anti-cancer compound. However, the company's core competency was developing biotechnology tools that would be used to identify highly qualified pre-clinical leads.
SIGNATURE BIOSCIENCE
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1998-01-01
Address:
Hayward, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Total Funding:
58.96 M USD
Similar Organizations
NeoGenesis Pharmaceuticals
A drug discovery company which uses it proprietary affinity-based screening technologies and integrated chemical library
Quanta BioDesign
The Quanta BioDesign dPEG® product line is a unique technology platform.
Founder
Investors List
Prospect Venture Partners
Prospect Venture Partners investment in Series E - Signature BioScience
Shelter Growth Capital Partners
Shelter Growth Capital Partners investment in Series E - Signature BioScience
Atlas Venture
Atlas Venture investment in Series E - Signature BioScience
Coral Ventures
Coral Ventures investment in Series E - Signature BioScience
Abingworth
Abingworth investment in Series E - Signature BioScience
Shelter Growth Capital Partners
Shelter Growth Capital Partners investment in Series D - Signature BioScience
More informations about "Signature BioScience"
Signature BioScience - Wikipedia
Signature BioScience Inc. was the first biotechnology company based in San Francisco. It was formed in 1998 but closed in 2003 due to lack of funding. Before Signature was dissolved, it had just completed Phase II trials on Digitoxin, which the company was pursuing as an anti-cancer compound. However, the company's core competency was developing biotechnology tools that would be used to identify highly qualified pre-clinical leads. See details»
Signatur Biosciences Company Profile 2024: Valuation, …
Signatur Biosciences General Information Description. Developer of a PCR testing platform designed to make precision diagnostics accessible to all. The company's technology uses the molecular machinery of PCR to condense all …See details»
Signatur Biosciences: Simple tests for complex diseases. - Y …
Signature BioScience - Crunchbase Company Profile & Funding
Signature BioScience Inc. was the first biotechnology company based in San Francisco. It was formed in 1998 but closed in 2003 due to lack of funding. Before Signature was dissolved, it …See details»
Signature BioScience, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 9, 2023 Explore Signature BioScience, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, and 10 literature, Drug:SN-4071.See details»
Team — SIGNATUR BIO
First patent at 15. World Intellectual Property Organization Best Young Inventor 2010. Twice TEDx speaker. Co-founded Young Change Maker, a social startup that highlights inspiring individuals. Co-founded and sold a company called …See details»
Signatur Biosciences - Crunchbase Company Profile & Funding
Organization. Signatur Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Signatur Biosciences is bringing …See details»
Technology — SIGNATUR BIO
Our PCRchitectur platform is a breakthrough technology that expands PCR testing to a whole new range of conditions, beyond just infectious disease. With PCRchitectur, supporting treatment selection, and disease monitoring is made …See details»
Signature BioScience - Crunchbase
Biotech company creating a drug-screening technology platformSee details»
Signature Bioscience Inc - Patent Buddy
View Signature Bioscience Inc, organization profile on Patent Buddy. View Signature Bioscience Inc's patent attorneys, patent agents, growth curve and experience.See details»
Signature Raises $17M Privately For PhenoDynamic Technology
Sep 7, 2000 The Series C amount brings Signature BioScience's funding total to $21 million since its founding in 1998. SBS uses proprietary label-free bioassay systems and …See details»
Start-up Signatur Biosciences launched — The Stevens Group
Jun 1, 2022 We are excited to announce the launch of Signatur Biosciences, commercialising smart PCR kits based on our innovative PCRchitecture platform. ... Top Image: the founders of …See details»
SIGNATURE BIOSCIENCE INC innovation strategy - GoodIP
SIGNATURE BIOSCIENCE INC has a total of 68 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property …See details»
Signature BioScience - Tech Stack, Apps, Patents & Trademarks
Organization. Signature BioScience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
Signature Science Company Profile - Office Locations ... - Craft
Signature Science is a scientific consulting and services firm offering physical, life, forensic, and data science-related technical solutions and technologies. It provides research and …See details»
Signature BioScience - Overview, News & Similar companies
Who is Signature BioScience. Signature is a detection-based drug discovery company committed to efficiently delivering pre-clinical leads with the highest chance for clinical s uccess. The …See details»
Signature Bioscience - Products, Competitors, Financials, …
Signature Bioscience is a Healthcare/Biotechnology company based in Burlingame, California. Signature Bioscience's investors include Abingworth Management, Lotus Biosciences, Vulcan …See details»
Signature Bioscience - Nature Biotechnology
Signature Bioscience is also developing software tools that can translate the raw data into valuable information. Within two years, revenue will be generated by licensing out a “package” …See details»
Signature BioScience - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 20, 2002: ... Series E - …See details»
Extrasinusoidal macrophages are a distinct subset of …
17 hours ago The dura mater hosts a diverse set of innate and adaptive immune cells (7, 9–11).Single-cell RNA sequencing (scRNA-seq) of CD45 + cells from the dura of 12-week-old …See details»